Related Experiment Videos

Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics

J F Kurtzke1, K Hyllested

  • 1Neuroepidemiology Research Program, Veterans Administration Medical Center, Washington, DC.

Insights

Multiple sclerosis (MS) in the Faroe Islands occurred in three distinct epidemics, suggesting a widespread infectious origin. The disease appears to be acquired in adolescence and early adulthood, with a long incubation period before clinical symptoms emerge.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Neurology

Background:

  • Multiple Sclerosis (MS) incidence in the Faroe Islands has been historically high, with distinct epidemic patterns observed.
  • Previous studies suggested a potential link between MS and environmental or infectious factors in isolated populations.

Purpose of the Study:

  • To analyze the temporal and incidence trends of three distinct Multiple Sclerosis (MS) epidemics in the Faroe Islands.
  • To investigate the characteristics of primary MS affection (PMSA) and its relationship with clinical neurologic MS (CNMS).

Main Methods:

  • Retrospective analysis of MS cases among Faroese residents from 1943 to 1973.
  • Categorization of cases based on epidemic periods and age of onset (specifically age 11).
  • Calculation of MS risk per 10,000 population for each epidemic wave.

Main Results:

  • Three MS epidemics were identified, occurring sequentially with decreasing incidence.
  • The risk of MS for the first epidemic, linked to World War II British troops, was 18 per 10,000.
  • Subsequent epidemic risks (Epidemic II: 15-18/10,000; Epidemic III: 9-11/10,000) did not significantly differ from the first, suggesting a common underlying cause.

Conclusions:

  • Clinical MS (CNMS) likely results from a single, widespread, systemic infectious disease (primary MS affection - PMSA).
  • PMSA acquisition occurs in susceptible populations between ages 11 and 45, with transmission possible during a specific phase.
  • A significant incubation period (6-12 years) precedes CNMS, with only a fraction of infected individuals developing clinical disease.

Related Concept Videos